Arsenic speciation analysis of urine samples from individuals living in an arsenic-contaminated area in Bangladesh

Environmental Health and Preventive Medicine

Volumn 17, Issue 3, 2012, Pages 235-245

  Hata, Akihisa ^a,b   Yamanaka, Kenzo ^c   Habib, Mohamed Ahsan ^a   Endo, Yoko ^d   Fujitani, Noboru ^b   Endo, Ginji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA INSTITUTE OF SCIENCE   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

Arsenic; Drinking water; HPLC ICP MS; Speciation analysis; Urine

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; DRINKING WATER;

ADULT; AGED; ARSENIC POISONING; ARTICLE; BANGLADESH; CONCENTRATION (PARAMETERS); ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; SPECIES DIFFERENTIATION; URINALYSIS; WATER CONTENT; WATER POLLUTION;

ADULT; AGED; ARSENATES; ARSENIC; ARSENICALS; ARSENITES; BANGLADESH; BIOLOGICAL MARKERS; CACODYLIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRINKING WATER; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; LINEAR MODELS; MALE; MASS SPECTROMETRY; MIDDLE AGED; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

EID: 84862977449     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-011-0247-5     Document Type: Article

References (47)

1. Dhar RKr, Biswas BKr, Samanta G, BKr Mandal, Chakraborti D, Roy S, et al. Groundwater arsenic calamity in Bangladesh. Curr Sci. 1997;73:48-59.
2. Smith AH, Lingas EO, Rahman M. Contamination of drinkingwater by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78:1093-103.
3. Habib A, Hayashi T, Sato KK, Hata A, Ikebe M, Rahman F, et al. Effectiveness of arsenic mitigation program in Bangladesh - relationship between arsenic concentrations in well water and urine. Osaka City Med J. 2007;53:97-103.
4. International Agency for Research on Cancer (IARC). Some drinking water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum. 2004;84:36-267.
5. Vahter M. Mechanisms of arsenic biotransformation. Toxicology. 2002;181-182:211-7.
6. Wei M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G, et al. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 2002;23:1387-97.
7. Kligerman AD, Doerr CL, Tennant AH, Harrington-Brock K, Allen JW, Winkfield E, et al. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ Mol Mutagen. 2003;42:192-205.
8. Yamanaka K, Kato K, Mizoi M, An Y, Takabayashi F, Nakano M, et al. The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol Appl Pharmacol. 2004;198:385-93.
9. Mizoi M, Takabayashi F, Nakano M, An Y, Sagesaka Y, Kato K, et al. The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress. Toxicol Lett. 2005;158:87-94.
10. International Agency for Research on Cancer (IARC). Agents classified by the IARC monographs, vol 1-100. Lyon: IARC. http://monographs.iarc.fr/ENG/ Classification/Classifications AlphaOrder.pdf (2010). Accessed 10 Dec 2010.
11. Hopenhayn-Rich C, BiggsML, Smith AH, Kalman DA,Moore LE. Methylation study of a population environmentally exposed to arsenic in drinkingwater. Environ Health Perspect. 1996;104:620-8.
12. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control. 2003;14:303-10.
13. Tseng CH. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007;25:1-22.
14. Chowdhury UK, Rahman MM, Sengupta MK, Lodh D, Chanda CR, Roy S, et al. Pattern of excretion of arsenic compounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of children compared to adults from an arsenic exposed area in Bangladesh. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003;38:87-113.
15. MezaMM, KopplinMJ, Burgess JL, Gandolfi AJ. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico. Environ Res. 2004;96:119-26.
16. Parvez F, Chen Y, Brandt-Rauf PW, Bernard A, Dumont X, Slavkovich V, et al. Nonmalignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ Health Perspect. 2008;116:190-5.
17. Hata A, Endo Y, Nakajima Y, Ikebe M, Ogawa M, Fujitani N, et al. HPLC-ICP-MS speciation analysis of arsenic in urine of Japanese subjects without occupational exposure. J Occup Health. 2007;49:217-23.
18. Nakajima Y, Endo Y, Inoue Y, Yamanaka K, Kato K, Wanibuchi H, et al. Ingestion of Hijiki seaweed and risk of arsenic poisoning. Appl Organometal Chem. 2006;20:557-64.
19. German Federal Environment Agency. Standardisation of substance concentrations in urine. Creatinine. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2005;48:616-8.
20. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005;113:192-200.
21. Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health. 1981;48:111-8.
22. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for arsenic. Georgia: ATSRD, U.S. Department of Health and Human Services; 2007.
23. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev. 2007;16:1270-8.
24. Tseng CH. A review on environmental factors regulating arsenic methylation in humans. ToxicolAppl Pharmacol. 2009;235:338-50.
25. Tokunaga H, Roychowdhury T, Uchino T, Ando M. Urinary arsenic species in arsenic-affected area of West Bengal, India (Part II). J Health Sci. 2003;46:464-74.
26. Chiou H-Y, Hsueh Y-M, Hsieh L-L, Hsu L-I, Hsu Y-H, Hsieh F-I, et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferaseM1 and T1among current arsenicexposed residents in Taiwan. Mutat Res. 1997;386:197-207.
27. Del Razo LM, Garcia-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, et al. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol. 1997;71:211-7.
28. Yu RC, Hsu KH, Chen CJ, Froines JR. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:1259-62.
29. McCarty KM, Chen YC, Quamruzzaman Q, Rahman M, Mahiuddin G, Hsueh YM, et al. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect. 2007;115:341-5.
30. Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, et al. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect. 2009;117:455-60.
31. Watanabe C, Inaoka T, Kadono T, Nagano M, Nakamura S, Ushijima K, et al. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ Health Perspect. 2001;109:1265-70.
32. Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, et al. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol. 2009;239:184-92.
33. Morton J, Mason H. Speciation of arsenic compounds in urine from occupationally unexposed and exposed persons in the U.K. using a routine LC-ICP-MS method. J Anal Toxicol. 2006;30: 293-301.
34. Suzuki Y, Shimoda Y, Endo Y, Hata A, Yamanaka K, Endo G. Rapid and effective speciation analysis of arsenic compounds in human urine using anion-exchange columns in HPLC-ICP-MS. J Occup Health. 2009;51:380-5.
35. Apostoli P, Bartoli D, Alessio L, Buchet JP. Biological monitoring of occupational exposure to inorganic arsenic. Occup Environ Med. 1999;56:825-32.
36. Deutsche Forschungsgemeinschaft (DFG). Arsenic and inorganic arsenic compounds. Essential BAT value documentations. Weinheim: Wiley; 2006.
37. Meharg AA, Rahman MM. Arsenic contamination of Bangladesh paddy field soils: implications for rice contribution to arsenic consumption. Environ Sci Technol. 2003;37:229-34.
38. Das HK, Mitra AK, Sengupta PK, Hossain A, Islam F, Rabbani GH. Arsenic concentrations in rice, vegetables, and fish in Bangladesh: a preliminary study. Environ Int. 2004;30:383-7.
39. Williams PN, Price AH, Raab A, Hossain SA, Feldmann J, Meharg AA. Variation in arsenic speciation and concentration in paddy rice related to dietary exposure. Environ Sci Technol. 2005;39:5531-40.
40. Smith NM, Lee R, Heitkemper DT, DeNicola Cafferky K, Haque A, Henderson AK. Inorganic arsenic in cooked rice and vegetables from Bangladeshi households. Sci Total Environ. 2006; 370:294-301.
41. Bae M, Watanabe C, Inaoka T, Sekiyama M, Sudo N, Bokul MH, et al. Arsenic in cooked rice in Bangladesh. Lancet. 2002; 360:1839-40.
42. Orloff K, Mistry K, Metcalf S. Biomonitoring for environmental exposures to arsenic. J Toxicol Environ Health B Crit Rev. 2009;12:509-24.
43. Parvez F, Chen Y, Argos M, Hussain AZ, Momotaj H, Dhar R, et al. Prevalence of arsenic exposure from drinking water and awareness of its health risks in a Bangladeshi population: results from a large population-based study. Environ Health Perspect. 2006;114:355-9.
44. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, et al. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol. 2005;206:299-308.
45. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, Hussain I, et al. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am J Epidemiol. 2006;163:1138-48.
46. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, et al. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect. 2005;113:1683-8.
47. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, et al. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect. 2009;117:254-60.